What are the NCCN guidelines for evaluation of women with clinical stage IIIA (T3, N1, M0) breast cancer?

Updated: Feb 04, 2021
  • Author: Pavani Chalasani, MD, MPH; Chief Editor: John V Kiluk, MD, FACS  more...
  • Print

For women with clinical stage lllA (T3, N1, M0) disease, tests to consider are as follows:

  • CBC
  • Comprehensive metabolic panel, including LFTs and alkaline phosphatase
  • Chest diagnostic CT with contrast
  • Abdominal ± pelvic diagnostic CT with contrast or MRI with contrast
  • Bone scan or sodium fluoride PET/CT (category 2B)
  • FDG PET/CT (optional)

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!